NCT00788723

Brief Summary

The aim of the study is to evaluate the cortical excitability in the severe brain injured patients. We hypothesize that:

  1. 1.There is a continuous decrease in intracortical inhibition from healthy subjects to awake patients with severe brain injury, and to patients with impaired consciousness.
  2. 2.Decreased intracortical inhibition correlate with the degree of impairment assessed with the clinical scores in patients with severe brain injury.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2008

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2008

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 10, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 11, 2008

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2009

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2009

Completed
Last Updated

November 11, 2008

Status Verified

November 1, 2008

Enrollment Period

8 months

First QC Date

November 10, 2008

Last Update Submit

November 10, 2008

Conditions

Keywords

Severe Brain InjuryExcitabilityTranscranial Magnetic Stimulation

Outcome Measures

Primary Outcomes (1)

  • Short Afferent Inhibition

    Within one week after clinical assessment

Secondary Outcomes (3)

  • Short Intracortical Inhibition

    Within one week after clinical assessment

  • Intracortical Facilitation

    Within one week after clinical assessment

  • Motor threshold

    Within one week after clinical assessment

Study Arms (3)

1

EXPERIMENTAL

Patients with severe brain injury, awake, but have cognitive problems

Device: Transcranial Magnetic Stimulation

2

EXPERIMENTAL

Patients with severe brain injury and disorders of consciousness ( in minimally conscious or in vegetative state)

Device: Transcranial Magnetic Stimulation

3

EXPERIMENTAL

Healthy volunteers

Device: Transcranial Magnetic Stimulation

Interventions

Transcranial magnetic stimulation (TMS) using paired-pulse technique at different interstimulus intervals (ISIs) allows the study of the excitatory and inhibitory system of human motor cortex non-invasively. Motor evoked potentials (MEP) will be recorded, and stored on a VikingSelect (Viasys Healthcare, USA). Two magnetic stimulators (Magstim 200, The Magstim Company Ltd, U.K.) connected through a Bistim and a Magstim figure-of-eight coil will be used for TMS.

Also known as: Paired-pulse transcanial magnetic stimulation
123

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • severe brain injury (Glasgow Coma Scale score (GCS) less than 8 on admission to the acute hospital);
  • stable vital functions;
  • age over 18 years old;
  • informed content from patient/relatives/legal guardian.

You may not qualify if:

  • other neurological diseases than brain injury;
  • pregnancy;
  • TMS contraindications (epilepsy, metallic implantants: pacemaker or medicine pump, ferromagnetic or electronically operated stapedial implants, haemostatic clips, metallic splinters in the orbit).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hammel Neurorehabilitation and Research Centre

Hammel, 8450, Denmark

RECRUITING

MeSH Terms

Conditions

Brain Injuries, TraumaticSubarachnoid HemorrhageHypoxia-Ischemia, BrainBrain Injuries

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesIntracranial HemorrhagesCerebrovascular DisordersVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsBrain IschemiaHypoxia, BrainHypoxiaSigns and Symptoms, RespiratorySigns and Symptoms

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Officials

  • Natallia Lapitskaya, MD

    Hammel Neurorehabilitation and Research Centre

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Natallia Lapitskaya, MD

CONTACT

Lena Bjorn, secretary

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 10, 2008

First Posted

November 11, 2008

Study Start

July 1, 2008

Primary Completion

March 1, 2009

Study Completion

May 1, 2009

Last Updated

November 11, 2008

Record last verified: 2008-11

Locations